Pharmacological therapy in children with atrial fibrillation and atrial flutter

Salvatore Novo, Gaspare Barbaro, Giuseppina Novo, Claudia Visconti, Luciana D'Angelo, Giovanni Fazio, Giuseppe Barbaro, Giuseppe Barbaro, Giovanni Fazio, Luciana D'Angelo

Risultato della ricerca: Article

10 Citazioni (Scopus)

Abstract

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontain's surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, previous response to alternative treatment options, convenience and patient preference for a specific treatment option, and costeffectiveness of a treatment option are among the many factors that should be considered. Treatment of atrial flutter and fibrillation in pediatric age involves several options: Pharmacological therapy, Transoesophageal atrial pacing (TEAP), Electrical cardioversion and Catheter ablation. In this review we evaluated the physiopathology, the clinical features and the current terapeutical strategies for these arrythmias in paediatric age
Lingua originaleEnglish
pagine (da-a)770-775
Numero di pagine6
RivistaCURRENT PHARMACEUTICAL DESIGN
Volume14
Stato di pubblicazionePublished - 2008

Fingerprint

Atrial Flutter
Atrial Fibrillation
Pharmacology
Pediatrics
Cardiac Arrhythmias
Therapeutics
Electric Countershock
Catheter Ablation
Patient Preference
Dilatation
Heart Diseases
History
Incidence
Population

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cita questo

Pharmacological therapy in children with atrial fibrillation and atrial flutter. / Novo, Salvatore; Barbaro, Gaspare; Novo, Giuseppina; Visconti, Claudia; D'Angelo, Luciana; Fazio, Giovanni; Barbaro, Giuseppe; Barbaro, Giuseppe; Fazio, Giovanni; D'Angelo, Luciana.

In: CURRENT PHARMACEUTICAL DESIGN, Vol. 14, 2008, pag. 770-775.

Risultato della ricerca: Article

Novo, S, Barbaro, G, Novo, G, Visconti, C, D'Angelo, L, Fazio, G, Barbaro, G, Barbaro, G, Fazio, G & D'Angelo, L 2008, 'Pharmacological therapy in children with atrial fibrillation and atrial flutter', CURRENT PHARMACEUTICAL DESIGN, vol. 14, pagg. 770-775.
Novo, Salvatore ; Barbaro, Gaspare ; Novo, Giuseppina ; Visconti, Claudia ; D'Angelo, Luciana ; Fazio, Giovanni ; Barbaro, Giuseppe ; Barbaro, Giuseppe ; Fazio, Giovanni ; D'Angelo, Luciana. / Pharmacological therapy in children with atrial fibrillation and atrial flutter. In: CURRENT PHARMACEUTICAL DESIGN. 2008 ; Vol. 14. pagg. 770-775.
@article{d2aa921e992d4122870609a05aec760f,
title = "Pharmacological therapy in children with atrial fibrillation and atrial flutter",
abstract = "Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontain's surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, previous response to alternative treatment options, convenience and patient preference for a specific treatment option, and costeffectiveness of a treatment option are among the many factors that should be considered. Treatment of atrial flutter and fibrillation in pediatric age involves several options: Pharmacological therapy, Transoesophageal atrial pacing (TEAP), Electrical cardioversion and Catheter ablation. In this review we evaluated the physiopathology, the clinical features and the current terapeutical strategies for these arrythmias in paediatric age",
keywords = "PHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.",
author = "Salvatore Novo and Gaspare Barbaro and Giuseppina Novo and Claudia Visconti and Luciana D'Angelo and Giovanni Fazio and Giuseppe Barbaro and Giuseppe Barbaro and Giovanni Fazio and Luciana D'Angelo",
year = "2008",
language = "English",
volume = "14",
pages = "770--775",
journal = "CURRENT PHARMACEUTICAL DESIGN",
issn = "1381-6128",

}

TY - JOUR

T1 - Pharmacological therapy in children with atrial fibrillation and atrial flutter

AU - Novo, Salvatore

AU - Barbaro, Gaspare

AU - Novo, Giuseppina

AU - Visconti, Claudia

AU - D'Angelo, Luciana

AU - Fazio, Giovanni

AU - Barbaro, Giuseppe

AU - Barbaro, Giuseppe

AU - Fazio, Giovanni

AU - D'Angelo, Luciana

PY - 2008

Y1 - 2008

N2 - Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontain's surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, previous response to alternative treatment options, convenience and patient preference for a specific treatment option, and costeffectiveness of a treatment option are among the many factors that should be considered. Treatment of atrial flutter and fibrillation in pediatric age involves several options: Pharmacological therapy, Transoesophageal atrial pacing (TEAP), Electrical cardioversion and Catheter ablation. In this review we evaluated the physiopathology, the clinical features and the current terapeutical strategies for these arrythmias in paediatric age

AB - Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontain's surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, previous response to alternative treatment options, convenience and patient preference for a specific treatment option, and costeffectiveness of a treatment option are among the many factors that should be considered. Treatment of atrial flutter and fibrillation in pediatric age involves several options: Pharmacological therapy, Transoesophageal atrial pacing (TEAP), Electrical cardioversion and Catheter ablation. In this review we evaluated the physiopathology, the clinical features and the current terapeutical strategies for these arrythmias in paediatric age

KW - PHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.

UR - http://hdl.handle.net/10447/39783

M3 - Article

VL - 14

SP - 770

EP - 775

JO - CURRENT PHARMACEUTICAL DESIGN

JF - CURRENT PHARMACEUTICAL DESIGN

SN - 1381-6128

ER -